This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Jul-Aug:6 Suppl 1:S1-9.

doi: 10.1046/j.1524-4733.6.s1.1.x.

The drug budget silo mentality in Europe: an overview

Lou Garrison¹, Adrian Towse

Affiliations

PMID: 12846921
DOI: 10.1046/j.1524-4733.6.s1.1.x

Free article

Review

The drug budget silo mentality in Europe: an overview

Lou Garrison et al. Value Health. 2003 Jul-Aug.

Free article

. 2003 Jul-Aug:6 Suppl 1:S1-9.

doi: 10.1046/j.1524-4733.6.s1.1.x.

Authors

Lou Garrison¹, Adrian Towse

Affiliation

¹ Health Economics & Strategic Pricing, Roche Pharmaceuticals, Basel, Switzerland; Office of Health Economics, London, UK. lou.garrison@roche.com

PMID: 12846921
DOI: 10.1046/j.1524-4733.6.s1.1.x

No abstract available

PubMed Disclaimer

Similar articles

Moving beyond the drug budget silo mentality in Europe.
Drummond M, Jönsson B. Drummond M, et al. Value Health. 2003 Jul-Aug;6 Suppl 1:S74-7. doi: 10.1046/j.1524-4733.6.s1.8.x. Value Health. 2003. PMID: 12846928 No abstract available.
The drug budget silo mentality: the French case.
Le Pen C. Le Pen C. Value Health. 2003 Jul-Aug;6 Suppl 1:S10-9. doi: 10.1046/j.1524-4733.6.s1.2.x. Value Health. 2003. PMID: 12846922
Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany.
Schwermann T, Greiner W, v d Schulenburg JM. Schwermann T, et al. Value Health. 2003 Jul-Aug;6 Suppl 1:S20-30. doi: 10.1046/j.1524-4733.6.s1.3.x. Value Health. 2003. PMID: 12846923
Comparative approaches to pharmaceutical price regulation in the European Union.
Mrazek MF. Mrazek MF. Croat Med J. 2002 Aug;43(4):453-61. Croat Med J. 2002. PMID: 12187524 Review.
Pharmaceutical management strategies of industrialized countries.
Brier KL. Brier KL. Formulary. 1995 Oct;30(10):606-10, 614. Formulary. 1995. PMID: 10151724 Review.

See all similar articles

Cited by

Pharmaceutical policies: effects of financial incentives for prescribers.
Rashidian A, Omidvari AH, Vali Y, Sturm H, Oxman AD. Rashidian A, et al. Cochrane Database Syst Rev. 2015 Aug 4;2015(8):CD006731. doi: 10.1002/14651858.CD006731.pub2. Cochrane Database Syst Rev. 2015. PMID: 26239041 Free PMC article.
Defining and Measuring the Affordability of New Medicines: A Systematic Review.
Antoñanzas F, Terkola R, Overton PM, Shalet N, Postma M. Antoñanzas F, et al. Pharmacoeconomics. 2017 Aug;35(8):777-791. doi: 10.1007/s40273-017-0514-4. Pharmacoeconomics. 2017. PMID: 28477220
Physiotherapists' perspectives of barriers and facilitators to effective community provision after hip fracture: a qualitative study in England.
Adams J, Jones GD, Sadler E, Guerra S, Sobolev B, Sackley C, Sheehan KJ. Adams J, et al. Age Ageing. 2023 Sep 1;52(9):afad130. doi: 10.1093/ageing/afad130. Age Ageing. 2023. PMID: 37756647 Free PMC article.
Doctors' attitudes about prescribing and knowledge of the costs of common medications.
McGuire C, King S, Roche-Nagle G, Barry MC. McGuire C, et al. Ir J Med Sci. 2009 Sep;178(3):277-80. doi: 10.1007/s11845-009-0276-x. Epub 2009 Feb 17. Ir J Med Sci. 2009. PMID: 19221833
Trends in pharmaceutical expenditure in the Taiwan National Health Insurance database at different hospital levels.
Chung CH. Chung CH. J Comp Eff Res. 2023 Feb;12(2):e220162. doi: 10.2217/cer-2022-0162. Epub 2022 Dec 13. J Comp Eff Res. 2023. PMID: 36511826 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources